News and Updates

Glucagon. It’s a word familiar to people with T1D, yet one most hope to avoid discussing. But what is glucagon and what is its role in the management of T1D?

Connected insulin pens and pen caps offer people with type 1 diabetes (T1D) a different way to use technology to manage and deliver insulin.  

The FDA authorized the Insulet Omnipod 5, the world’s first tubeless, wearable system, for children 2+, using an algorithm that began by Breakthrough T1D funding.

The name Jambo might not be familiar to you, but to more than 22,000 Twitch users and 38,000 Twitter followers, she’s a gaming influencer.

Congratulations to Dr. Albanese-O'Neill, director of screening and clinical trials, who was honored with the Diabetes Care and Education Specialist of the Year Award!

JDRF-funded researchers in Colorado and Germany found no link between COVID-19 and type 1 diabetes in children and adolescents ages 1-18.

Congress passes the Inflation Reduction Act, which contains provisions that will make insulin affordable for some Americans. Much more must be done.

Misdiagnosing adults with type 1 diabetes (T1D) is an all-too-common problem that can have tragic consequences. Breakthrough T1D and IQVIA partnered up to tackle it—and the results were just published.

Breakthrough T1D Urges Senate to Support Insulin Affordability Provisions as Part of Inflation Reduction Act of 2022

Learn more about the recipients of the International Society for Pediatrics and Adolescent Diabetes (ISPAD)-Breakthrough T1D Fellowships here!